Science in Dyslipidemia Disease
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
ODYSSEY Outcomes
NEJM Odyssey Outcomes
The EXPLORER Study
The ROSETTE Study
Odyssey Outcomes - Mortality
The ACTE Study
Odyssey Outcomes - CABG Results
Odyssey Outcomes - PVD Results
PCSK9 inhibitors and ACS
Odyssey Outcomes - DM sub-analysis
ESC/EAS 2019 International Guidelines
Odyssey Outcomes - Elderly Patients Results
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
Improving Lipid Management for Patients Post-ACS
Atherosclerosis: Identifying risks and improving outcomes
Lp(a) as ASCVD Risk Factor
Lipid Management in Patients with ACS/ASCVD
Act Now for Your ACS Patients: Summary
Statin/ezetimibe SPC for better adherence to LLT
Act Now for Your ACS Patients: Patient Identification
EAS guidance regarding combining lipid-modifying therapy
Identifying and Treating Patients with High Lipidaemia Risk Post-ACS
Act Now for Your ACS Patients: Optimise Your ACS Pathway
Metabolic Risk Factors and Effect of Alirocumab on CV Events
Lp(a) and PCSK9 inhibition in nominally controlled LDL-C
Events
Stay up to date and register for the latest events and view webinar recordings.
24:30
Dyslipidemia Webinars: Optimizing Dyslipidemia management
Dyslipidemia Webisodes: Mortality data with Prof. Tunon
